Adagene Inc. American Depositary Shares — Quarterly Financial Statements (NASDAQ:ADAG) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Market Capitalization 166.61 M
Employee 138
Founded 2011
CEO N/A
Website www.adagene.com
Headquarter Cayman Islands
FIGI BBG00YZ6BYJ6
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

166.61 M Market capitalization

Price to earnings ratio

-3.37

Price to sales ratio

—

Dividends per share

—

Dividend yield %

—

Notizie

Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders

FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug

Il titolo di Adagene sale dopo che la FDA concede lo status Fast Track alla terapia contro il cancro

Adagene stock soars after FDA grants Fast Track status for cancer therapy

La FDA concede lo stato di fast track a muzastotug di Adagene per il cancro colorettale

FDA grants fast track status to Adagene’s muzastotug for colorectal cancer

Adagene somministra il primo paziente nello studio di Fase 2 di muzastotug per MSS CRC

Adagene doses first patient in Phase 2 trial of muzastotug for MSS CRC

All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Le azioni Adani in rialzo dopo che la SEBI respinge le accuse di Hindenburg

Adani shares rally as SEBI dismisses Hindenburg allegations